Capsule, caplet, tablet or powder: keep the form in the name

FDA’s structured product-labeling terminology lists capsules, tablets and powders as distinct dosage forms, along with more specific variants. This is a vocabulary resource for identifying forms, not a rule that every consumer product in a category performs alike. The complete name can also include a coating, release description or other qualifier that should not be dropped casually. In this publication, pills remains a broad entry phrase. The reviews preserve the actual manufacturer’s capsule wording. That small editorial choice prevents a tablet-based direction, a powder preparation instruction or a bottle count from being attached to the wrong physical item. FDA dosage-form terminology

The reviewed Full House panel identifies hypromellose as its capsule ingredient. NOW names a cellulose capsule, while Metamucil’s hundred-capsule facts image lists gelatin. Those are examples from exact public records, not a claim that every capsule uses one material. A familiar shell description does not disclose every ingredient amount or resolve an allergy question. The three-product comparison keeps the shell record beside each preparation’s distinct facts panel. Calling a fiber plant based also does not make every component of its finished capsule plant based. No conclusion about individual tolerance follows from the shell name or its appearance in a photograph. Full House NOW Metamucil

The National Cancer Institute’s terminology defines a caplet as a solid tablet compressed into a capsule-like shape. The similarity is in shape; it does not turn the object into the same construction as a capsule. This definition can prevent a practical labeling mistake without supplying directions for a particular product. None of the three principal products reviewed here is renamed a caplet. If a retailer uses that word while the manufacturer uses a different form, the discrepancy deserves clarification. The vocabulary entry is a general definition and cannot authenticate a package, establish a manufacturer’s claim or demonstrate that two similarly shaped items can replace one another. NCI caplet definition

FDA’s vocabulary distinguishes a plain tablet from forms described as chewable, delayed release, extended release or orally disintegrating. That list is not a recommendation for any fiber shopper; it illustrates why the rest of a form name matters. A visual resemblance cannot establish those characteristics. This guide therefore provides no crushing, splitting, chewing or swallowing instructions based on a photograph or a search result. The professional-question guide addresses uncertainty about the actual preparation. A pharmacist can help explain a specific label, while an individualized care decision needs the relevant clinical context. The form vocabulary remains descriptive, not a personal handling guide. FDA dosage forms

A powder packet is not a capsule with the shell already removed. DailyMed’s exact Metamucil Therapy for Regularity record describes a particular orange-flavored powder packet, with its own active-ingredient declaration, other ingredients, Drug Facts uses and warnings. That record cannot supply instructions for the US capsule supplement simply because both use the Metamucil name. The Metamucil capsule review makes the boundary explicit. It would also be inaccurate to import the capsule panel’s ingredient list into that powder. Form, category and formula all need to match before a source can answer even a straightforward question about what a package declares. Exact powder label

A bottle may be counted in capsules, a box in packets and a powder container by net weight. Their facts panels can then use different serving bases. None of those units is automatically equivalent to one day or to a serving of another preparation. The servings and days guide explains the counting distinction, and the NOW review shows how a per-capsule name coexists with a multi-capsule serving. This guide does not build a conversion table because the records do not establish interchangeable effects, and personal use is not determined by arithmetic. Keeping the units written out is more useful than forcing unlike records into one number. FDA supplement labeling guidance

A useful question identifies the exact product, its form and the part of the label that is unclear. The manufacturer can clarify a public image, shell material or package version; a pharmacist or clinician can address individual swallowing, medicine or care questions. NIH recommends sharing an accurate record of supplements and medicines with healthcare professionals. The fixed category and form reader keeps these roles separate without collecting that record. It does not choose a preparation, authorize a form change or assess a symptom. A more precise noun improves the conversation, but it is not a substitute for the professional judgement the question may require. NIH supplement information